Prognostic Significance of CA IX Overexpression in Stage III NSCLC Patients Received Neoadjuvant Treatment

dc.contributor.author	HANCER, Veysel
dc.contributor.author	SAGLAM, Esra Kaytan
dc.contributor.author	Saglam, Sezer
dc.contributor.author	Disci, Rian
dc.contributor.author	BUYUKDOGAN, Murat
dc.contributor.author	Ibis, Kamuran
dc.contributor.author	Firat, Pinar
dc.contributor.author	Ozkan, Berker
dc.contributor.author	Toker, Alper
dc.contributor.author	Yilmazbayhan, Dilek
dc.date.accessioned	2021-03-05T21:25:02Z
dc.date.available	2021-03-05T21:25:02Z
dc.date.issued	2017
dc.identifier.citation	Saglam S., Ibis K., SAGLAM E. K. , Firat P., Yilmazbayhan D., Toker A., Ozkan B., HANCER V., BUYUKDOGAN M., Disci R., "Prognostic Significance of CA IX Overexpression in Stage III NSCLC Patients Received Neoadjuvant Treatment", JOURNAL OF THORACIC ONCOLOGY, cilt.12, 2017
dc.identifier.issn	1556-0864
dc.identifier.other	vv_1032021
dc.identifier.other	av_d8bcdcbd-d73d-4892-b040-14e0f3e93952
dc.identifier.uri	http://hdl.handle.net/20.500.12627/142996
dc.language.iso	eng
dc.subject	Göğüs Hastalıkları ve Allerji
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	SOLUNUM SİSTEMİ
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	Onkoloji
dc.subject	İç Hastalıkları
dc.title	Prognostic Significance of CA IX Overexpression in Stage III NSCLC Patients Received Neoadjuvant Treatment
dc.type	Makale
dc.relation.journal	JOURNAL OF THORACIC ONCOLOGY
dc.contributor.department	İstinye Üniversitesi , ,
dc.identifier.volume	12
dc.identifier.issue	1
dc.contributor.firstauthorID	100444

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.